Skip to content
GenoLensGenoLens

RDH5

Chr 12q13.2

retinol dehydrogenase 5

Aliases:
HSD17B9, SDR9C5
MANE:
ENST00000257895.10

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Retinal disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Glaucoma (developmental)

  • Structural eye disease

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Disease associations (Open Targets)

  • fundus albipunctatus

    0.84
  • Retinal dystrophy

    0.51
  • myopia

    0.46
  • age-related macular degeneration

    0.44
  • retinitis punctata albescens

    0.44
  • congenital stationary night blindness

    0.43
  • Hypermetropia

    0.40
  • refractive error

    0.40
  • retinal disorder

    0.39
  • COVID-19

    0.39

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Retinol dehydrogenase 5

Catalyzes the oxidation of cis-isomers of retinol, including 11-cis-, 9-cis-, and 13-cis-retinol in an NAD-dependent manner (PubMed:10588954, PubMed:11675386, PubMed:9115228, PubMed:9931293). Has no activity towards all-trans retinal (By similarity). Plays a significant role in 11-cis retinol oxidation in the retinal pigment epithelium cells (RPE). Also recognizes steroids (androsterone, androstanediol) as its substrates (PubMed:29541409, PubMed:9931293)

Curated MONDO disease pages that list RDH5 among their top associated genes.

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.